Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children

NCT: NCT06960239 · COMPLETED

NCT IDNCT06960239
StatusCOMPLETED
Start Date2024-11-14
Completion2025-10-22
SponsorENTire Medical Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a multi-center, prospective, open-label, traditional feasibility study with a before-after study design. The study is designed to evaluate the safety and efficacy of an Irreversible Electroporation (IRE) System for the treatment of upper airway obstruction due to adenotonsillar hypertrophy in Children.

Frequently Asked Questions

What is Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children?

Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children is a clinical trial registered under NCT06960239. Current status: COMPLETED.

What is the status of NCT06960239?

The current status of NCT06960239 (Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children) is: COMPLETED.

When did Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children start?

Safety and Efficacy of the Irreversible Electroporation (IRE) System for Adenotonsillar Hypertrophy in Children started on 2024-11-14.

Related Devices

K251996ENTire IRE SystemEntire Medical , Ltd. K261202ENTire IRE SystemEntire Medical , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑